Nora Therapeutics Obtains $18,000,000 Series B Financing

  • Feed Type
  • Date
    4/17/2014
  • Company Name
    Nora Therapeutics
  • Mailing Address
    530 Lytton Ave. 2nd Floor Palo Alto, CA 94301 USA
  • Company Description
    Nora Therapeutics is a specialty biopharmaceutical company focused on developing therapeutics to address clinical unmet needs in reproductive medicine.
  • Website
    http://www.noratherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    We are further encouraged that enrollment in the THRIVE-IVF trial is ahead of schedule and we have already received significant investigator interest for the upcoming RESPONSE trial.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy